Is there a cardiovascular rationale for the use of combined vasopressin V1a/V2 receptor antagonists? (Q36537083)

From Wikidata
Jump to navigation Jump to search
scientific article published on July 2006
edit
Language Label Description Also known as
English
Is there a cardiovascular rationale for the use of combined vasopressin V1a/V2 receptor antagonists?
scientific article published on July 2006

    Statements

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit